<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35709984</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>298</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Proximity-based labeling reveals DNA damage-induced phosphorylation of fused in sarcoma (FUS) causes distinct changes in the FUS protein interactome.</ArticleTitle><Pagination><StartPage>102135</StartPage><MedlinePgn>102135</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102135</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2022.102135</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(22)00576-2</ELocationID><Abstract><AbstractText>Accumulation of cytoplasmic inclusions containing fused in sarcoma (FUS), an RNA/DNA-binding protein, is a common hallmark of frontotemporal lobar degeneration and amyotrophic lateral sclerosis neuropathology. We have previously shown that DNA damage can trigger the cytoplasmic accumulation of N-terminally phosphorylated FUS. However, the functional consequences of N-terminal FUS phosphorylation are unknown. To gain insight into this question, we utilized proximity-dependent biotin labeling via ascorbate peroxidase 2 aired with mass spectrometry to investigate whether N-terminal phosphorylation alters the FUS protein-protein interaction network (interactome), and subsequently, FUS function. We report the first analysis comparing the interactomes of three FUS variants: homeostatic wildtype FUS (FUS WT), phosphomimetic FUS (FUS PM; a proxy for N-terminally phosphorylated FUS), and the toxic FUS proline 525 to leucine mutant (FUS P525L) that causes juvenile amyotrophic lateral sclerosis. We found that the phosphomimetic FUS interactome is uniquely enriched for a group of cytoplasmic proteins that mediate mRNA metabolism and translation, as well as nuclear proteins involved in the spliceosome and DNA repair functions. Furthermore, we identified and validated the RNA-induced silencing complex RNA helicase MOV10 as a novel interacting partner of FUS. Finally, we provide functional evidence that N-terminally phosphorylated FUS may disrupt homeostatic translation and steady-state levels of specific mRNA transcripts. Taken together, these results highlight phosphorylation as a unique modulator of the interactome and function of FUS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Michelle A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, Georgia, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nuckols</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, Georgia, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merino</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, Georgia, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagchi</LastName><ForeName>Pritha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Emory Integrated Proteomics Core, Emory University, School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nandy</LastName><ForeName>Srijita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, Georgia, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Root</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, Georgia, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, Georgia, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seyfried</LastName><ForeName>Nicholas T</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, Georgia, USA; Emory Integrated Proteomics Core, Emory University, School of Medicine, Atlanta, Georgia, USA; Department of Neurology, Emory University, School of Medicine, Atlanta, Georgia, USA; Department of Biochemistry, Emory University, School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kukar</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, Georgia, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, Georgia, USA; Department of Neurology, Emory University, School of Medicine, Atlanta, Georgia, USA. Electronic address: Thomas.Kukar@emory.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS093362</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS105971</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG079318</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 NS096050</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C530476">Mov10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="Y">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">fused in sarcoma</Keyword><Keyword MajorTopicYN="N">phosphorylation</Keyword><Keyword MajorTopicYN="N">protein translocation</Keyword><Keyword MajorTopicYN="N">protein&#x2013;protein interaction</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword><Keyword MajorTopicYN="N">translation</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>16</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35709984</ArticleId><ArticleId IdType="pmc">PMC9372748</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2022.102135</ArticleId><ArticleId IdType="pii">S0021-9258(22)00576-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bang J., Spina S., Miller B.L. Frontotemporal dementia. Lancet. 2015;386:1672&#x2013;1682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann D.M.A., Snowden J.S. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype. Brain Pathol. 2017;27:723&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029341</ArticleId><ArticleId IdType="pubmed">28100023</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y.A., Fratta P., Traynor B.J., Chia R. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front. Neurosci. 2020;14:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell J.R., Kiernan M.C., Vucic S., Hodges J.R. Motor neuron dysfunction in frontotemporal dementia. Brain. 2011;134:2582&#x2013;2594.</Citation><ArticleIdList><ArticleId IdType="pubmed">21840887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Moglia C., Canosa A., Manera U., Vasta R., Brunetti M., et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93:e984&#x2013;e994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6745732</ArticleId><ArticleId IdType="pubmed">31409738</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A., Neumann M. Fused in sarcoma neuropathology in neurodegenerative disease. Cold Spring Harb. Perspect. Med. 2017;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710099</ArticleId><ArticleId IdType="pubmed">28096243</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Jr., Al-Chalabi A. Amyotrophic lateral sclerosis. N.&#xa0;Engl. J. Med. 2017;377:1602.</Citation><ArticleIdList><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A., Mackenzie I.R. A&#xa0;new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132:2922&#x2013;2931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Roeber S., Kretzschmar H.A., Rademakers R., Baker M., Mackenzie I.R. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 2009;118:605&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864784</ArticleId><ArticleId IdType="pubmed">19669651</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Bentmann E., Dormann D., Jawaid A., DeJesus-Hernandez M., Ansorge O., et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. 2011;134:2595&#x2013;2609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M., Talbot K., Ansorge O. Pathogenesis of FUS-associated ALS and FTD: Insights from rodent models. Acta Neuropathol. Commun. 2016;4:99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Svetoni F., Frisone P., Paronetto M.P. Role of FET proteins in neurodegenerative disorders. RNA Biol. 2016;13:1089&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5100351</ArticleId><ArticleId IdType="pubmed">27415968</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Mackenzie I.R.A. Review: neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol. Appl. Neurobiol. 2019;45:19&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">30357887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R., Kapogiannis D., Huey E.D., Momeni P. FTD and ALS: a tale of two diseases. Curr. Alzheimer Res. 2011;8:273&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R., Santini L., Colantoni A., Peruzzi G., de Turris V., Alfano V., et al. FUS mutant human motoneurons display altered transcriptome and microRNA pathways with implications for ALS pathogenesis. Stem Cell Rep. 2017;9:1450&#x2013;1462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830977</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii R., Okabe S., Urushido T., Inoue K., Yoshimura A., Tachibana T., et al. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 2005;15:587&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">15797031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Arenas A., Zhai J., Zhu H., et al. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim. Biophys. Acta. 2016;1862:2004&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5055831</ArticleId><ArticleId IdType="pubmed">27460707</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama R.R., Ward C.L., Kaushansky L.J., Lemay N., Ishigaki S., Urano F., et al. FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stress. J.&#xa0;Cell Physiol. 2013;228:2222&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000275</ArticleId><ArticleId IdType="pubmed">23625794</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Ebmeier C.C., Podell E.R., Heimiller J., Taatjes D.J., Cech T.R. FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev. 2012;26:2690&#x2013;2695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3533074</ArticleId><ArticleId IdType="pubmed">23249733</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Robinson H.K., Connor-Robson N., Buchman V.L. Recruitment into stress granules prevents irreversible aggregation of FUS protein mislocalized to the cytoplasm. Cell Cycle. 2013;12:3194&#x2013;3202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3865015</ArticleId><ArticleId IdType="pubmed">24013423</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Gal J., Chen J., Zhu H. Self-assembled FUS binds active chromatin and regulates gene transcription. Proc. Natl. Acad. Sci. U. S. A. 2014;111:17809&#x2013;17814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4273402</ArticleId><ArticleId IdType="pubmed">25453086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H., Sok J., Immanuel D., Yin Y., Ron D. TLS (FUS) binds RNA in&#xa0;vivo and engages in nucleo-cytoplasmic shuttling. J.&#xa0;Cell Sci. 1997;110:1741&#x2013;1750.</Citation><ArticleIdList><ArticleId IdType="pubmed">9264461</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.C., McGoldrick P., Vance C., Hortobagyi T., Sreedharan J., Rogelj B., et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Sendscheid O., El Oussini H., Jambeau M., Sun Y., Mersmann S., et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35:1077&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H., Lee S., Shang Y., Wang W.Y., Au K.F., Kamiya S., et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J.&#xa0;Clin. Invest. 2014;124:981&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiihashi G., Ito D., Yagi T., Nihei Y., Ebine T., Suzuki N. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain. 2016;139:2380&#x2013;2394.</Citation><ArticleIdList><ArticleId IdType="pubmed">27368346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., et al. ALS/FTD-Linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2018;100:816&#x2013;830.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Broustal O., Camuzat A., Guillot-Noel L., Guy N., Millecamps S., Deffond D., et al. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J.&#xa0;Alzheimers Dis. 2010;22:765&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pubmed">21158017</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden J.S., Hu Q., Rollinson S., Halliwell N., Robinson A., Davidson Y.S., et al. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol. 2011;122:99&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">21424531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden H.A., Dormann D. Altered mRNP granule dynamics in FTLD pathogenesis. J.&#xa0;Neurochem. 2016;138:112&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">26938019</ArticleId></ArticleIdList></Reference><Reference><Citation>Darovic S., Prpar Mihevc S., Zupunski V., Guncar G., Stalekar M., Lee Y.B., et al. Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import. J.&#xa0;Cell Sci. 2015;128:4151&#x2013;4159.</Citation><ArticleIdList><ArticleId IdType="pubmed">26403203</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Madl T., Valori C.F., Bentmann E., Tahirovic S., Abou-Ajram C., et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 2012;31:4258&#x2013;4275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J., Demestre M., Putz S., Delling J.P., Jacob C., Lutz A.K., et al. FUS mislocalization and vulnerability to DNA damage in ALS patients derived hiPSCs and aging motoneurons. Front. Cell Neurosci. 2016;10:290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5183648</ArticleId><ArticleId IdType="pubmed">28082870</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzino C., Monaghan J., Milioto C., Lanson N.A., Jr., Maltare A., Aggarwal T., et al. Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in&#xa0;vitro and in&#xa0;vivo. PLoS One. 2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631215</ArticleId><ArticleId IdType="pubmed">23620769</ArticleId></ArticleIdList></Reference><Reference><Citation>Singatulina A.S., Hamon L., Sukhanova M.V., Desforges B., Joshi V., Bouhss A., et al. PARP-1 activation directs FUS to DNA damage sites to form PARG-reversible compartments enriched in damaged DNA. Cell Rep. 2019;27:1809&#x2013;1821.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31067465</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeeck C., Deng Q., Dejesus-Hernandez M., Taylor G., Ceballos-Diaz C., Kocerha J., et al. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol. Neurodegener. 2012;7:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3519790</ArticleId><ArticleId IdType="pubmed">23046583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubersax J.A., Ferrell J.E., Jr. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 2007;8:530&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">17585314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenreiro S., Eckermann K., Outeiro T.F. Protein phosphorylation in neurodegeneration: friend or foe? Front. Mol. Neurosci. 2014;7:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4026737</ArticleId><ArticleId IdType="pubmed">24860424</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E.M.J., Orie V.K., Williams T., Baker M.R., De Oliveira H.M., Polvikoski T., et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J.&#xa0;Neurol. Neurosurg. Psychiatry. 2020;92:86&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803890</ArticleId><ArticleId IdType="pubmed">33177049</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z., Ryan V.H., Janke A.M., Burke K.A., Rhoads S.N., Zerze G.H., et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 2017;36:2951&#x2013;2967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray D.T., Kato M., Lin Y., Thurber K.R., Hung I., McKnight S.L., et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell. 2017;171:615&#x2013;627.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q., Holler C.J., Taylor G., Hudson K.F., Watkins W., Gearing M., et al. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J.&#xa0;Neurosci. 2014;34:7802&#x2013;7813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4044245</ArticleId><ArticleId IdType="pubmed">24899704</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann C.A., Campos-Melo D., Ishtiaq M., Volkening K., Strong M.J. RNA metabolism in ALS: when normal processes become pathological. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:321&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">24555412</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson M.A., Deng Q., Taylor G., McEachin Z.T., Chan A.W.S., Root J., et al. Divergent FUS phosphorylation in primate and mouse cells following double-strand DNA damage. Neurobiol. Dis. 2020;146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064403</ArticleId><ArticleId IdType="pubmed">32950644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.Y., Pan L., Su S.C., Quinn E.J., Sasaki M., Jimenez J.C., et al. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat. Neurosci. 2013;16:1383&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmroth K., Nygren J., Martensson S., Ismail I.H., Hammarsten O. Cleavage of cellular DNA by calicheamicin gamma1. DNA Repair (Amst) 2003;2:363&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">12606118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam S.S., Martell J.D., Kamer K.J., Deerinck T.J., Ellisman M.H., Mootha V.K., et al. Directed evolution of APEX2 for electron microscopy and proximity labeling. Nat. Methods. 2015;12:51&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4296904</ArticleId><ArticleId IdType="pubmed">25419960</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Birsa N., Milioto C., McLaughlin M., Ule A.M., Robaldo D., et al. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucl. Acids Res. 2020;48:6889&#x2013;6905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone M.G., Alfano V., Salvatori B., Braccia C., Peruzzi G., Colantoni A., et al. Proteomics analysis of FUS mutant human motoneurons reveals altered regulation of cytoskeleton and other ALS-linked proteins via 3'UTR binding. Sci. Rep. 2020;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366621</ArticleId><ArticleId IdType="pubmed">32678235</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Wang H., Cai Y., Wen H., Wang L., Zhu M., et al. FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders. Brain Behav. 2020;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303404</ArticleId><ArticleId IdType="pubmed">32307925</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte A., Lattante S., Zollino M., Marangi G., Luigetti M., Del Grande A., et al. P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis. Neuromuscul. Disord. 2012;22:73&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21907581</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads S.N., Monahan Z.T., Yee D.S., Leung A.Y., Newcombe C.G., O'Meally R.N., et al. The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization. Mol. Biol. Cell. 2018;29:1786&#x2013;1797.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6085830</ArticleId><ArticleId IdType="pubmed">29897835</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel L., Avequin T., Delarue M., Feuillette S., Frebourg T., Campion D., et al. Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila. Neurobiol. Aging. 2012 doi: 10.1016/j.neurobiolaging.2011.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.008</ArticleId><ArticleId IdType="pubmed">22118902</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura T., Watanabe S., Kaneko K., Yamanaka K., Nukina N., Furukawa Y. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis. J.&#xa0;Biol. Chem. 2014;289:1192&#x2013;1202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3887186</ArticleId><ArticleId IdType="pubmed">24280224</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii S., Takanashi K., Kitajo K., Yamaguchi A. Treatment with a global methyltransferase inhibitor induces the intranuclear aggregation of ALS-linked FUS mutant in&#xa0;vitro. Neurochem. Res. 2016;41:826&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pubmed">26603295</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H., Liu G., Mellacheruvu D., Tyers M., Gingras A.C., Nesvizhskii A.I. Analyzing protein-protein interactions from affinity purification-mass spectrometry data with SAINT. Curr. Protoc. Bioinformatics. 2012 doi: 10.1002/0471250953.bi0815s39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471250953.bi0815s39</ArticleId><ArticleId IdType="pmc">PMC3446209</ArticleId><ArticleId IdType="pubmed">22948729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., Chang M., Khodabakhshi A.H., Tanaseichuk O., et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.D.R., Choi H., Gupta G.D., Pelletier L., Raught B., Nesvizhskii A.I., et al. ProHits-viz: A suite of web tools for visualizing interaction proteomics data. Nat. Methods. 2017;14:645&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831326</ArticleId><ArticleId IdType="pubmed">28661499</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S., Jutzi D., Lindsay H., Devoy A., Mechtersheimer J., Levone B.R., et al. The phase separation-dependent FUS interactome reveals nuclear and cytoplasmic function of liquid-liquid phase separation. Nucl. Acids Res. 2021;49:7713&#x2013;7731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287939</ArticleId><ArticleId IdType="pubmed">34233002</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucl. Acids Res. 2019;47:D607&#x2013;D613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovar H. Dr Jekyll and Mr. Hyde: the two faces of the FUS/EWS/TAF15 protein family. Sarcoma. 2011;2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3005952</ArticleId><ArticleId IdType="pubmed">21197473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Jin H., Kasarskis E.J., Zhu H. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc. Natl. Acad. Sci. U. S. A. 2018;115:E11904&#x2013;E11913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S., Soltanieh S., Server K.L., Mak R., Jin W., Fang M.Y., et al. Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell. 2018;172:590&#x2013;604.e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Scotter E.L., Nishimura A.L., Troakes C., Mitchell J.C., Kathe C., et al. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum. Mol. Genet. 2013;22:2676&#x2013;2688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Salvio M., Piccinni V., Gerbino V., Mantoni F., Camerini S., Lenzi J., et al. Pur-alpha functionally interacts with FUS carrying ALS-associated mutations. Cell Death Dis. 2015;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632316</ArticleId><ArticleId IdType="pubmed">26492376</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Onesto E., Megiorni F., Pizzuti A., Baralle F.E., Buratti E., et al. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J.&#xa0;Biol. Chem. 2012;287:15635&#x2013;15647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3346140</ArticleId><ArticleId IdType="pubmed">22427648</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., Wang E.T., Friedman B.A., Keagle P.J., Lowe P., Leclerc A.L., et al. Characterization of FUS mutations in amyotrophic lateral sclerosis using RNA-Seq. PLoS One. 2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3620060</ArticleId><ArticleId IdType="pubmed">23577159</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna S., Wen J. Nonsense-mediated mRNA decay (NMD) mechanisms. Nat. Struct. Mol. Biol. 2009;16:107&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">19190664</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavysh D., Neu-Yilik G. UPF1-Mediated RNA decay-danse macabre in a cloud. Biomolecules. 2020;10:999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7407380</ArticleId><ArticleId IdType="pubmed">32635561</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman C.A., Hornberger T.A. Measuring protein synthesis with SUnSET: a valid alternative to traditional techniques? Exerc. Sport Sci. Rev. 2013;41:107&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951011</ArticleId><ArticleId IdType="pubmed">23089927</ArticleId></ArticleIdList></Reference><Reference><Citation>Root J., Merino P., Nuckols A., Johnson M., Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol. Dis. 2021;154</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113138</ArticleId><ArticleId IdType="pubmed">33812000</ArticleId></ArticleIdList></Reference><Reference><Citation>Longatti A., Orsi A., Tooze S.A. Autophagosome formation: not necessarily an inside job. Cell Res. 2010;20:1181&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">20838417</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg T.O., Fengsrud M., Stromhaug P.E., Berg T., Seglen P.O. Isolation and characterization of rat liver amphisomes. Evidence for fusion of autophagosomes with both early and late endosomes. J.&#xa0;Biol. Chem. 1998;273:21883&#x2013;21892.</Citation><ArticleIdList><ArticleId IdType="pubmed">9705327</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.B., Seglen P.O. Prelysosomal convergence of autophagic and endocytic pathways. Biochem. Biophys. Res. Commun. 1988;151:40&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">3126737</ArticleId></ArticleIdList></Reference><Reference><Citation>Orhon I., Reggiori F. Assays to monitor autophagy progression in cell cultures. Cells. 2017;6:20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617966</ArticleId><ArticleId IdType="pubmed">28686195</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron D.M., Kaushansky L.J., Ward C.L., Sama R.R., Chian R.J., Boggio K.J., et al. Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics. Mol. Neurodegener. 2013;8:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766239</ArticleId><ArticleId IdType="pubmed">24090136</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi J., De Santis R., de Turris V., Morlando M., Laneve P., Calvo A., et al. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons. Dis. Model Mech. 2015;8:755&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486861</ArticleId><ArticleId IdType="pubmed">26035390</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S., Stettler J., Filosa G., Colombo M., Jutzi D., Lenzken S.C., et al. Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants. EMBO J. 2016;35:1504&#x2013;1521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4946139</ArticleId><ArticleId IdType="pubmed">27252488</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2018;9:712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron D.M., Matheny T., Lin Y.C., Leszyk J.D., Kenna K., Gall K.V., et al. Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS. Hum. Mol. Genet. 2019;28:2143&#x2013;2160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6586143</ArticleId><ArticleId IdType="pubmed">30806671</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J.D., Guerreiro R., Vandrovcova J., Uphill J., Reiman D., Beck J., et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73:1451&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779007</ArticleId><ArticleId IdType="pubmed">19884572</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravenscroft T.A., Baker M.C., Rutherford N.J., Neumann M., Mackenzie I.R., Josephs K.A., et al. Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS. Neurobiol. Aging. 2013 doi: 10.1016/j.neurobiolaging.2013.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.04.004</ArticleId><ArticleId IdType="pmc">PMC3683824</ArticleId><ArticleId IdType="pubmed">23635657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E., Gordon D., Thompson A.G., Finelli M.J., Dafinca R., Candalija A., et al. An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress. Neurobiol. Dis. 2020;144</Citation><ArticleIdList><ArticleId IdType="pubmed">32800996</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M., Hutten S., Bourgeois B., Spreitzer E., Niedner-Boblenz A., Schifferer M., et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell. 2018;173:706&#x2013;719.e13.</Citation><ArticleIdList><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama R.R., Fallini C., Gatto R., McKeon J.E., Song Y., Rotunno M.S., et al. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci. Rep. 2017;7:115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428330</ArticleId><ArticleId IdType="pubmed">28273913</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Drexler H.C.A., Wang J., Tripathi P., Distler T., Heisterkamp P., et al. FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 2019;138:67&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani M., Zhao B., Gentil B.J., Minotti S., Marques C., Keith J., et al. Dysregulation of chromatin remodelling complexes in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2017;26:4142&#x2013;4152.</Citation><ArticleIdList><ArticleId IdType="pubmed">28973294</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S., Wang G., Randle S.J., Ruggeri F.S., Varela J.A., Lin J.Q., et al. FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-pi interactions. Cell. 2018;173:720&#x2013;734. e715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Kim H.J., Wang H., Monaghan J., Freyermuth F., Sung J.C., et al. Nuclear-import receptors Reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell. 2018;173:677&#x2013;692.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.C., Chook Y.M. Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS) Proc. Natl. Acad. Sci. U. S. A. 2012;109:12017&#x2013;12021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409756</ArticleId><ArticleId IdType="pubmed">22778397</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodier J.L., Cheung L.E., Kazazian H.H., Jr. MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet. 2012;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3475670</ArticleId><ArticleId IdType="pubmed">23093941</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Ju S., Arjun A., Batarse A., Archbold H.C., Peisach D., et al. Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1. Proc. Natl. Acad. Sci. U. S. A. 2015;112:7821&#x2013;7826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4485101</ArticleId><ArticleId IdType="pubmed">26056265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendell J.T., Sharifi N.A., Meyers J.L., Martinez-Murillo F., Dietz H.C. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat. Genet. 2004;36:1073&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448691</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva A.L., Ribeiro P., Inacio A., Liebhaber S.A., Romao L. Proximity of the poly(A)-binding protein to a premature termination codon inhibits mammalian nonsense-mediated mRNA decay. RNA. 2008;14:563&#x2013;576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2248256</ArticleId><ArticleId IdType="pubmed">18230761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Eshov A., Zhou J., Isiktas A.U., Guo J.U. C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression. Nat. Commun. 2020;11:3354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7335171</ArticleId><ArticleId IdType="pubmed">32620797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega J.A., Daley E.L., Kour S., Samani M., Tellez L., Smith H.S., et al. Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS/FTD C9orf72 toxicity. Neuron. 2020;106:90&#x2013;107.e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272217</ArticleId><ArticleId IdType="pubmed">32059759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.Y., Agrawal I., Tyan S.H., Sanford E., Chang W.T., Lim K., et al. Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits. Acta Neuropathol. Commun. 2021;9:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789430</ArticleId><ArticleId IdType="pubmed">33407930</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosaki T., Popp M.W., Maquat L.E. Quality and quantity control of gene expression by nonsense-mediated mRNA decay. Nat. Rev. Mol. Cell Biol. 2019;20:406&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6855384</ArticleId><ArticleId IdType="pubmed">30992545</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohini M., Haritha Menon A., Selvamurugan N. Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions. Int. J. Biol. Macromol. 2018;120:310&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">30144543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Li X., Guo M., Yu J., Yan C. The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation. BMC Genomics. 2016;17:335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4857411</ArticleId><ArticleId IdType="pubmed">27146783</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H.Y., Wek S.A., McGrath B.C., Lu D., Hai T.W., Harding H.P., et al. Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol. Cell Biol. 2004;24:1365&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC321431</ArticleId><ArticleId IdType="pubmed">14729979</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Lou C.H., Chan W., Shum E.Y., Shao A., Stone E., et al. RNA homeostasis governed by cell type-specific and branched feedback loops acting on NMD. Mol. Cell. 2011;43:950&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281029</ArticleId><ArticleId IdType="pubmed">21925383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevigny M., Bourdeau Julien I., Venkatasubramani J.P., Hui J.B., Dutchak P.A., Sephton C.F. FUS contributes to mTOR-dependent inhibition of translation. J.&#xa0;Biol. Chem. 2020;295:18459&#x2013;18473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7939483</ArticleId><ArticleId IdType="pubmed">33082139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K., Zhang H., Loiselle D., Haystead T., Macara I.G., Mili S. The RNA-binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J.&#xa0;Cell Biol. 2013;203:737&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857475</ArticleId><ArticleId IdType="pubmed">24297750</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar B., Moreau K., Jahreiss L., Puri C., Rubinsztein D.C. Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat. Cell Biol. 2010;12:747&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2923063</ArticleId><ArticleId IdType="pubmed">20639872</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J., Abdel-Aziz A.K., Abdelfatah S., Abdellatif M., Abdoli A., Abel S., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1) Autophagy. 2021;17:1&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996087</ArticleId><ArticleId IdType="pubmed">33634751</ArticleId></ArticleIdList></Reference><Reference><Citation>Baade I., Hutten S., Sternburg E.L., P&#xf6;rschke M., Hofweber M., Dormann D., et al. The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors. J.&#xa0;Biol. Chem. 2021;296:100659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8131929</ArticleId><ArticleId IdType="pubmed">33857479</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyfried N.T., Dammer E.B., Swarup V., Nandakumar D., Duong D.M., Yin L., et al. A&#xa0;multi-network approach identifies protein-specific Co-expression in asymptomatic and symptomatic Alzheimer's disease. Cell Syst. 2017;4:60&#x2013;72.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5269514</ArticleId><ArticleId IdType="pubmed">27989508</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova S., Temu T., Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 2016;11:2301&#x2013;2319.</Citation><ArticleIdList><ArticleId IdType="pubmed">27809316</ArticleId></ArticleIdList></Reference><Reference><Citation>Gierlinski M., Gastaldello F., Cole C., Barton G.J. Proteus: an R package for downstream analysis of MaxQuant output. bioRxiv. 2018 doi: 10.1101/416511. preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/416511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie M.E., Phipson B., Wu D., Hu Y., Law C.W., Shi W., et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl. Acids Res. 2015;43:e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C.-H., Yu G., Cai P. ggVennDiagram: an intuitive, easy-to-use, and highly customizable R package to generate venn diagram. Front Genet. 2021;12:1598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452859</ArticleId><ArticleId IdType="pubmed">34557218</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain A., Begum N.A., Kobayashi M., Honjo T. Native Co-immunoprecipitation assay to identify interacting partners of chromatin-associated proteins in mammalian cells. Bio-Protocol. 2020;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7842739</ArticleId><ArticleId IdType="pubmed">33659486</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y., Csordas A., Bai J., Bernal-Llinares M., Hewapathirana S., Kundu D.J., et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucl. Acids Res. 2019;47:D442&#x2013;D450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323896</ArticleId><ArticleId IdType="pubmed">30395289</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>